The Reversal of Anticholinergic Drug-Induced Delirium and Coma with Physostigmine
Although its use for this purpose is not well recognized, physostigmine provides an effective and safe treatment for delirium and coma caused by anticholinergic agents such as atropine, scopolamine, and hyoscyamine. The authors summarize the supporting evidence and outline a recommended procedure.
Gespeichert in:
Veröffentlicht in: | The American journal of psychiatry 1971-02, Vol.127 (8), p.1050-1054 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1054 |
---|---|
container_issue | 8 |
container_start_page | 1050 |
container_title | The American journal of psychiatry |
container_volume | 127 |
creator | HEISER, JON F GILLIN, JOHN C |
description | Although its use for this purpose is not well recognized, physostigmine provides an effective and safe treatment for delirium and coma caused by anticholinergic agents such as atropine, scopolamine, and hyoscyamine. The authors summarize the supporting evidence and outline a recommended procedure. |
doi_str_mv | 10.1176/ajp.127.8.1050 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1310604196</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1310604196</sourcerecordid><originalsourceid>FETCH-LOGICAL-a354t-46ba5461a139fb6073b1b9c4b5680972c41ff6e26b4b53d760a214d18b80c1ae3</originalsourceid><addsrcrecordid>eNptkN1LwzAUxYMoc05ffRMCPkprbpOmzePY_BgIfjDBt5C26Zqxfpi0yv57MzbEB58u955zz4EfQpdAQoCE36p1F0KUhGkIJCZHaAwxjYMkitJjNCaERIGI6ccpOnNu7VdCk2iERjERQjA2Rq_LSuM3_aWtUxvclnja9Cav2o1ptF2ZHM_tsAoWTTHkusBzvTHWDDVWTYFnba3wt-kr_FJtXet6s6r91zk6KdXG6YvDnKD3-7vl7DF4en5YzKZPgaIx6wPGMxUzDgqoKDNOEppBJnKWxTwlIolyBmXJdcQzf6JFwomKgBWQZinJQWk6Qdf73M62n4N2vVy3g218pQQKhBMGgntXuHfltnXO6lJ21tTKbiUQuQMoPUDpAcpU7gD6h6tD7JDVuvi1H4h5_Wavq64zfyr_T_sBE0F4uA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1310604196</pqid></control><display><type>article</type><title>The Reversal of Anticholinergic Drug-Induced Delirium and Coma with Physostigmine</title><source>MEDLINE</source><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><source>Periodicals Index Online</source><creator>HEISER, JON F ; GILLIN, JOHN C</creator><creatorcontrib>HEISER, JON F ; GILLIN, JOHN C</creatorcontrib><description>Although its use for this purpose is not well recognized, physostigmine provides an effective and safe treatment for delirium and coma caused by anticholinergic agents such as atropine, scopolamine, and hyoscyamine. The authors summarize the supporting evidence and outline a recommended procedure.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/ajp.127.8.1050</identifier><identifier>PMID: 5099944</identifier><language>eng</language><publisher>United States: American Psychiatric Publishing</publisher><subject>Adult ; Atropa belladonna - adverse effects ; Atropine - adverse effects ; Coma - chemically induced ; Coma - drug therapy ; Delirium - chemically induced ; Delirium - drug therapy ; Humans ; Plants, Medicinal ; Plants, Toxic</subject><ispartof>The American journal of psychiatry, 1971-02, Vol.127 (8), p.1050-1054</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a354t-46ba5461a139fb6073b1b9c4b5680972c41ff6e26b4b53d760a214d18b80c1ae3</citedby><cites>FETCH-LOGICAL-a354t-46ba5461a139fb6073b1b9c4b5680972c41ff6e26b4b53d760a214d18b80c1ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/ajp.127.8.1050$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/ajp.127.8.1050$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,776,780,2845,21609,27848,27903,27904,77537,77538</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5099944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HEISER, JON F</creatorcontrib><creatorcontrib>GILLIN, JOHN C</creatorcontrib><title>The Reversal of Anticholinergic Drug-Induced Delirium and Coma with Physostigmine</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Although its use for this purpose is not well recognized, physostigmine provides an effective and safe treatment for delirium and coma caused by anticholinergic agents such as atropine, scopolamine, and hyoscyamine. The authors summarize the supporting evidence and outline a recommended procedure.</description><subject>Adult</subject><subject>Atropa belladonna - adverse effects</subject><subject>Atropine - adverse effects</subject><subject>Coma - chemically induced</subject><subject>Coma - drug therapy</subject><subject>Delirium - chemically induced</subject><subject>Delirium - drug therapy</subject><subject>Humans</subject><subject>Plants, Medicinal</subject><subject>Plants, Toxic</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1971</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNptkN1LwzAUxYMoc05ffRMCPkprbpOmzePY_BgIfjDBt5C26Zqxfpi0yv57MzbEB58u955zz4EfQpdAQoCE36p1F0KUhGkIJCZHaAwxjYMkitJjNCaERIGI6ccpOnNu7VdCk2iERjERQjA2Rq_LSuM3_aWtUxvclnja9Cav2o1ptF2ZHM_tsAoWTTHkusBzvTHWDDVWTYFnba3wt-kr_FJtXet6s6r91zk6KdXG6YvDnKD3-7vl7DF4en5YzKZPgaIx6wPGMxUzDgqoKDNOEppBJnKWxTwlIolyBmXJdcQzf6JFwomKgBWQZinJQWk6Qdf73M62n4N2vVy3g218pQQKhBMGgntXuHfltnXO6lJ21tTKbiUQuQMoPUDpAcpU7gD6h6tD7JDVuvi1H4h5_Wavq64zfyr_T_sBE0F4uA</recordid><startdate>197102</startdate><enddate>197102</enddate><creator>HEISER, JON F</creator><creator>GILLIN, JOHN C</creator><general>American Psychiatric Publishing</general><general>American Psychiatric Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HAWNG</scope><scope>HBMBR</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope></search><sort><creationdate>197102</creationdate><title>The Reversal of Anticholinergic Drug-Induced Delirium and Coma with Physostigmine</title><author>HEISER, JON F ; GILLIN, JOHN C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a354t-46ba5461a139fb6073b1b9c4b5680972c41ff6e26b4b53d760a214d18b80c1ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1971</creationdate><topic>Adult</topic><topic>Atropa belladonna - adverse effects</topic><topic>Atropine - adverse effects</topic><topic>Coma - chemically induced</topic><topic>Coma - drug therapy</topic><topic>Delirium - chemically induced</topic><topic>Delirium - drug therapy</topic><topic>Humans</topic><topic>Plants, Medicinal</topic><topic>Plants, Toxic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HEISER, JON F</creatorcontrib><creatorcontrib>GILLIN, JOHN C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 13</collection><collection>Periodicals Index Online Segment 14</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HEISER, JON F</au><au>GILLIN, JOHN C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Reversal of Anticholinergic Drug-Induced Delirium and Coma with Physostigmine</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>1971-02</date><risdate>1971</risdate><volume>127</volume><issue>8</issue><spage>1050</spage><epage>1054</epage><pages>1050-1054</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><abstract>Although its use for this purpose is not well recognized, physostigmine provides an effective and safe treatment for delirium and coma caused by anticholinergic agents such as atropine, scopolamine, and hyoscyamine. The authors summarize the supporting evidence and outline a recommended procedure.</abstract><cop>United States</cop><pub>American Psychiatric Publishing</pub><pmid>5099944</pmid><doi>10.1176/ajp.127.8.1050</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-953X |
ispartof | The American journal of psychiatry, 1971-02, Vol.127 (8), p.1050-1054 |
issn | 0002-953X 1535-7228 |
language | eng |
recordid | cdi_proquest_journals_1310604196 |
source | MEDLINE; Psychiatry Legacy Collection Online Journals 1844-1996; Periodicals Index Online |
subjects | Adult Atropa belladonna - adverse effects Atropine - adverse effects Coma - chemically induced Coma - drug therapy Delirium - chemically induced Delirium - drug therapy Humans Plants, Medicinal Plants, Toxic |
title | The Reversal of Anticholinergic Drug-Induced Delirium and Coma with Physostigmine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A11%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Reversal%20of%20Anticholinergic%20Drug-Induced%20Delirium%20and%20Coma%20with%20Physostigmine&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=HEISER,%20JON%20F&rft.date=1971-02&rft.volume=127&rft.issue=8&rft.spage=1050&rft.epage=1054&rft.pages=1050-1054&rft.issn=0002-953X&rft.eissn=1535-7228&rft_id=info:doi/10.1176/ajp.127.8.1050&rft_dat=%3Cproquest_cross%3E1310604196%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1310604196&rft_id=info:pmid/5099944&rfr_iscdi=true |